Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
University of Maryland, Baltimore
Children's Hospital of Michigan
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
University of Miami
H. Lee Moffitt Cancer Center and Research Institute
Peking University
Sun Yat-sen University
Johann Wolfgang Goethe University Hospital
PETHEMA Foundation
Sanofi